Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03217188 · ClinicalTrials.gov registry record · Phase 2
Proton Re-Irradiation for Recurrent Head and Neck Cancer
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 87
- Enrollment target
NCT03217188: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03217188 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 87 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03217188, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the tumor control and the side effects of using proton therapy for head and neck cancer that has come back.
Primary Outcome
Locoregional recurrence includes events of local and/or regional recurrence, or death due to any cause. Patients who are lost to follow-up without any event may be removed from the protocol at the discretion of the principal investigator.
Interventions
- RADIATION conventionally fractionated full dose re-irradiation
- RADIATION hypofractionated palliative re-irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2017-07-10 |
| Est. Completion | 2026-03-18 |
| Phase | Phase 2 |
What the finished NCT03217188 record still lists
NCT03217188 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% lower).
The record links to 0 conditions, and to 2 interventions - of which conventionally fractionated full dose re-irradiation is the first listed.
NCT03217188 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03217188 about?
NCT03217188 is a clinical study titled "Proton Re-Irradiation for Recurrent Head and Neck Cancer". The purpose of this study is to evaluate the tumor control and the side effects of using proton therapy for head and neck cancer that has come back.
What is the current status of trial NCT03217188?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 87 participants. The study started on 2017-07-10. Estimated completion is 2026-03-18.
What interventions are being tested in trial NCT03217188?
The interventions under investigation include: conventionally fractionated full dose re-irradiation (RADIATION), hypofractionated palliative re-irradiation (RADIATION).
Who is sponsoring clinical trial NCT03217188?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03217188's enrollment target sits among peer trials
87 810th of 2000 higher than 1,189 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI